Tandem Diabetes (TNDM) announced Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform. The app is expected to be available later this year.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes price target raised to $11 from $10.35 at Citi
- Tandem Diabetes Care: Strategic Growth Potential and Market Expansion Drive Buy Rating
- Tandem Diabetes upgraded to Neutral from Sell at Citi
- Tandem Diabetes Care: Upgraded to Neutral/High Risk Amid Valuation and Acquisition Interest
- Arm initiated, Adobe downgraded: Wall Street’s top analyst calls